We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Knee Cartilage Repair Technique Spurs Regeneration

By HospiMedica International staff writers
Posted on 31 Jul 2013
A natural tissue graft can stimulate regeneration and improve symptoms in patients who have cartilage damage to their knee, according to a new study.

Researchers at the Hospital for Special Surgery (HSS; New York, NY, USA) conducted a study that examined use of the De Novo natural tissue (NT) graft to treat 17 patients who suffered from focal patella-femoral cartilage lesions with an average lesion size of 203 millimeters. More...
The researchers compared symptom assessment and subjective survey scores of international knee documentation committee (IKDC) evaluation forms and magnetic resonance imaging (MRI) data at baseline and at two years of follow-up.

At follow-up, the patients had roughly a 30% improvement in IKDC health evaluation form scores, a 20% improvement in the IKDC subjective form, and a 25% improvement in the Knee Outcome Survey form. The patients also showed improvements on MRI scans, in both traditional MRI technology as well as quantitative T2 mapping. The improvement was demonstrated in both superficial and deep components of the repair tissue, demonstrating that it still differed from normal cartilage. The study was presented at the annual meeting of the American Orthopedic Society for Sports Medicine (AOSSM), held during July 2013, in Chicago (IL, USA).

The De Novo NT Graft, a product of Zimmer (Warsaw, IN, USA) is made of minced cartilage from organ donors under the age of 13. Unlike cartilage in adults, the younger tissue has a high proliferative capacity. Cells from the transplanted cartilage escape or migrate into surrounding area tissues, multiply, and form a new cartilage tissue matrix that integrates with the surrounding host tissue. The technique eliminates the need for tissue harvesting and requires less suturing, since the product uses a fibrin sealant to secure the particulated tissue pieces into the lesion.

“The small pieces of juvenile cartilage are less than a millimeter in size, and what happens is the cells can migrate out of these small pieces of cartilage,” said lead author and study presenter orthopedic surgeon Scott Rodeo, MD, co-chief of the sports medicine and shoulder service at the HSS. “De Novo NT compares favorably to our existing techniques, given that it is easy to do and involves a one-step procedure. We are cautiously optimistic. It clearly regenerates tissue, but we need further long-term follow up.”

Related Links:

Hospital for Special Surgery
Zimmer



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.